{
  "emaEpar": [],
  "fdaDrugLabel": [],
  "id": "Tositumomab",
  "nciThesaurus": {
    "casRegistry": "192391-48-3",
    "chebiId": "",
    "chemicalFormula": "",
    "definition": "A murine IgG2 monoclonal antibody directed against the CD20 antigen, found on the surface of B-cells.  Tositumomab binds to the CD20 surface membrane antigen, resulting in apoptosis, and may stimulate antitumoral cell-mediated and/or antibody-dependent cytotoxicity.",
    "fdaUniiCode": "0343IGH41U",
    "identifier": "C2543",
    "preferredName": "Tositumomab",
    "semanticType": "Amino Acid, Peptide, or Protein",
    "subclassOf": [
      "C129822",
      "C141215"
    ],
    "synonyms": [
      "Anti-CD20 Antibody",
      "MoAb Anti-B1",
      "Monoclonal Antibody Anti-B1",
      "TOSITUMOMAB",
      "Tositumomab",
      "anti-B1",
      "tositumomab"
    ]
  }
}